The Trial Innovation Network (TIN) is a national platform funded by the NIH as part of the Clinical and Translational Science Awards (CTSA) consortium. The vision for the TIN is to improve the efficiency and effectiveness of multi-site clinical trials through operational innovation, shared infrastructure, and collaboration across CTSA hubs. UCSF is a participating institution in the TIN through its Clinical and Translational Science Institute (CTSI).
Who is Eligible?
- Any UCSF investigator across all four schools (Dentistry, Medicine, Nursing, and Pharmacy) who is interested in collaborating on multi-site clinical trials initiated by other TIN network sitesThis includes faculty at UCSF-affiliated institutionssuch as Zuckerberg San Francisco General (ZSFG), San Francisco Veterans Affairs Health Care System (VA), and UCSF Benioff Children's Hospital Oakland (BCHO).
- Investigators who would like to join multi-site trials led by other institutions across the TIN network.
Note: At this time, UCSF is not submitting new outbound proposals for TIN support but remains an active partner inbound, network-initiated studies.
How Do You Participate?
- Inbound studies: UCSF researchers can participate in multi-site clinical trials initiated by other network sites. These study requests are sent to the UCSF TIN liaison team and then disseminated to investigators within the broader UCSF research community.
Services Provided for TIN Studies:
- Single IRB support, resources and tools, and web-based platform (IREx)
- Master contracting agreements
- Consultation on a variety of topics, such as study design and participant recruitment and engagement strategies
- EHR-based cohort assessment for informing study design and site selection
- Assistance in identifying study sites across the United States
If you have any questions regarding the Trial Innovation Network, please contact [email protected].